Tevogen Bio Inc.

1.10
-0.10 (-8.33%)
At close: Mar 31, 2025, 3:59 PM
1.10
-0.53%
After-hours: Mar 31, 2025, 05:57 PM EDT

Tevogen Bio Income Statement

Year FY23 FY22 FY21
Revenue n/a n/a n/a
Cost of Revenue n/a n/a n/a
Gross Profit n/a n/a n/a
Operating Income -8.84K -13.72M -4.62M
Interest Income n/a n/a n/a
Pretax Income -67.33K 4.41M -15.6M
Net Income -67.33K 4.41M -15.6M
Selling & General & Admin 2.27M 953.08K 1.66M
Research & Development n/a 5.77M 2.96M
Other Expenses n/a -7.38M -10.38M
Operating Expenses 2.27M 953.08K 4.62M
Interest Expense 256.03K n/a 598.5K
Selling & Marketing Expenses n/a n/a n/a
Cost & Expenses 2.27M 953.08K 4.62M
Income Tax n/a -230.82K -9.78M
Shares Outstanding (Basic) 165.42M 120M 120M
Shares Outstanding (Diluted) 165.42M 120M 120M
EPS (Basic) -0.00 0.04 -0.13
EPS (Diluted) -0.00 0.04 -0.13
EBITDA 188.71K -953.08K -28.75K
Depreciation & Amortization 197.55K 230.82K 9.38K